Literature DB >> 10328751

Synthesis and characterization of oligonucleotides containing 5',8-cyclopurine 2'-deoxyribonucleosides: (5'R)-5',8-cyclo-2'-deoxyadenosine, (5'S)-5',8-cyclo-2'-deoxyguanosine, and (5'R)-5',8-cyclo-2'-deoxyguanosine.

A Romieu1, D Gasparutto, J Cadet.   

Abstract

Radiation-induced degradation of purine and pyrimidine nucleosides gave rise to carbon-bridged cyclocompounds. Such cyclonucleosides represent a class of tandem lesions in which modification of both the base and 2-deoxyribose has occurred. A solid-phase synthetic method was designed for the incorporation of both 5'R and 5'S diastereoisomers of 5',8-cyclopurine 2'-deoxyribonucleosides into oligodeoxynucleotides to facilitate the assessment of the biochemical and biophysical features of such lesions. We report the preparation of the phosphoramidite synthons of (5'R)-5', 8-cyclo-2'-deoxyadenosine (2), (5'S)-5',8-cyclo-2'-deoxyguanosine (3), and (5'R)-5',8-cyclo-2'-deoxyguanosine (4). Fully protected compounds 10, 18, and 25 were then inserted into several oligonucleotides by automated procedures. Analysis of modified DNA oligomers 26-31 by electrospray mass spectrometry and enzymatic digestions with exo- and endonucleases confirmed the base compositions and the integrity of free radical-induced tandem lesions 2-4 that were chemically inserted.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10328751     DOI: 10.1021/tx9802668

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  23 in total

Review 1.  Biological properties of single chemical-DNA adducts: a twenty year perspective.

Authors:  James C Delaney; John M Essigmann
Journal:  Chem Res Toxicol       Date:  2007-12-12       Impact factor: 3.739

2.  Endonuclease and Exonuclease Activities on Oligodeoxynucleotides Containing Spiroiminodihydantoin Depend on the Sequence Context and the Lesion Stereochemistry.

Authors:  Xin Chen; Aaron M Fleming; James G Muller; Cynthia J Burrows
Journal:  New J Chem       Date:  2013-11-01       Impact factor: 3.591

3.  Measurement of 8-hydroxy-2'-deoxyguanosine in DNA by high-performance liquid chromatography-mass spectrometry: comparison with measurement by gas chromatography-mass spectrometry.

Authors:  M Dizdaroglu; P Jaruga; H Rodriguez
Journal:  Nucleic Acids Res       Date:  2001-02-01       Impact factor: 16.971

4.  Stability of N-glycosidic bond of (5'S)-8,5'-cyclo-2'-deoxyguanosine.

Authors:  Rajat S Das; Milinda Samaraweera; Martha Morton; José A Gascón; Ashis K Basu
Journal:  Chem Res Toxicol       Date:  2012-10-15       Impact factor: 3.739

5.  Structure of (5'S)-8,5'-cyclo-2'-deoxyguanosine in DNA.

Authors:  Hai Huang; Rajat S Das; Ashis K Basu; Michael P Stone
Journal:  J Am Chem Soc       Date:  2011-11-21       Impact factor: 15.419

Review 6.  The case for 8,5'-cyclopurine-2'-deoxynucleosides as endogenous DNA lesions that cause neurodegeneration in xeroderma pigmentosum.

Authors:  P J Brooks
Journal:  Neuroscience       Date:  2006-12-19       Impact factor: 3.590

7.  Synthesis of [1,3, NH2-(15)N3] (5'S)-8,5'-cyclo-2'-deoxyguanosine.

Authors:  Chanchal K Malik; Rajat S Das; Ashis K Basu
Journal:  J Labelled Comp Radiopharm       Date:  2013-05-23       Impact factor: 1.921

8.  Gamma and Ion-Beam Irradiation of DNA: Free Radical Mechanisms, Electron Effects, and Radiation Chemical Track Structure.

Authors:  Michael D Sevilla; David Becker; Anil Kumar; Amitava Adhikary
Journal:  Radiat Phys Chem Oxf Engl 1993       Date:  2016-04-30       Impact factor: 2.858

9.  Repair efficiency of (5'S)-8,5'-cyclo-2'-deoxyguanosine and (5'S)-8,5'-cyclo-2'-deoxyadenosine depends on the complementary base.

Authors:  Paritosh Pande; Rajat S Das; Clayton Sheppard; Yoke W Kow; Ashis K Basu
Journal:  DNA Repair (Amst)       Date:  2012-10-10

10.  Translesion synthesis of 8,5'-cyclopurine-2'-deoxynucleosides by DNA polymerases η, ι, and ζ.

Authors:  Changjun You; Ashley L Swanson; Xiaoxia Dai; Bifeng Yuan; Jianshuang Wang; Yinsheng Wang
Journal:  J Biol Chem       Date:  2013-08-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.